Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment

Journal of Proteome Research

Volumn 10, Issue 11, 2011, Pages 4925-4934

  Neiman, Maja ^a   Hedberg, Jesper J ^b   Dönnes, Pierre R ^b   Schuppe Koistinen, Ina ^b   Hanschke, Stephan ^c   Schindler, Ralf ^c   Uhlén, Mathias ^a   Schwenk, Jochen M ^a   Nilsson, Peter ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

affinity proteomics; antibody microarray; biomarker; fibulin 1; glomerulonephritis; kidney disorders; plasma profiling

Indexed keywords

FIBULIN; MONOCLONAL ANTIBODY; PLASMA PROTEIN; POLYCLONAL ANTIBODY;

ADULT; ANALGESIC AGENT ABUSE; ARTICLE; BIOTINYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; FEMALE; GLOMERULONEPHRITIS; HUMAN; KIDNEY DYSFUNCTION; MALE; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RELIABILITY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; MALE; MICROSPHERES; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; RENAL INSUFFICIENCY; ROC CURVE; YOUNG ADULT;

EID: 80655139676     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200286c     Document Type: Article

References (36)

1. Bonventre, J. V.; Vaidya, V. S.; Schmouder, R.; Feig, P.; Dieterle, F. Next-generation biomarkers for detecting kidney toxicity Nat. Biotechnol. 2010, 28 (5) 436-40
2. Sistare, F. D.; Dieterle, F.; Troth, S.; Holder, D. J.; Gerhold, D.; Andrews-Cleavenger, D.; Baer, W.; Betton, G.; Bounous, D.; Carl, K.; Collins, N.; Goering, P.; Goodsaid, F.; Gu, Y.-Z.; Guilpin, V.; Harpur, E.; Hassan, A.; Jacobson-Kram, D.; Kasper, P.; Laurie, D.; Lima, B. S.; Maciulaitis, R.; Mattes, W.; Maurer, G.; Obert, L. A.; Ozer, J.; Papaluca-Amati, M.; Phillips, J. A.; Pinches, M.; Schipper, M. J.; Thompson, K. L.; Vamvakas, S.; Vidal, J.-M.; Vonderscher, J.; Walker, E.; Webb, C.; Yu, Y. Towards consensus practices to qualify safety biomarkers for use in early drug development Nat. Biotechnol. 2010, 28 (5) 446-54
3. Waikar, S. S.; Bonventre, J. V. Creatinine kinetics and the definition of acute kidney injury J. Am. Soc. Nephrol. 2009, 20 (3) 672-9
4. Yu, Y.; Jin, H.; Holder, D.; Ozer, J. S.; Villarreal, S.; Shughrue, P.; Shi, S.; Figueroa, D. J.; Clouse, H.; Su, M.; Muniappa, N.; Troth, S. P.; Bailey, W.; Seng, J.; Aslamkhan, A. G.; Thudium, D.; Sistare, F. D.; Gerhold, D. L. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury Nat. Biotechnol. 2010, 28 (5) 470-7
5. Vaidya, V. S.; Ozer, J. S.; Dieterle, F.; Collings, F. B.; Ramirez, V.; Troth, S.; Muniappa, N.; Thudium, D.; Gerhold, D.; Holder, D. J.; Bobadilla, N. A.; Marrer, E.; Perentes, E.; Cordier, A.; Vonderscher, J.; Maurer, G.; Goering, P. L.; Sistare, F. D.; Bonventre, J. V. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies Nat. Biotechnol. 2010, 28 (5) 478-85
6. Ozer, J. S.; Dieterle, F.; Troth, S.; Perentes, E.; Cordier, A.; Verdes, P.; Staedtler, F.; Mahl, A.; Grenet, O.; Roth, D. R.; Wahl, D.; Legay, F.; Holder, D.; Erdos, Z.; Vlasakova, K.; Jin, H.; Yu, Y.; Muniappa, N.; Forest, T.; Clouse, H. K.; Reynolds, S.; Bailey, W. J.; Thudium, D. T.; Topper, M. J.; Skopek, T. R.; Sina, J. F.; Glaab, W. E.; Vonderscher, J.; Maurer, G.; Chibout, S.-D.; Sistare, F. D.; Gerhold, D. L. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function Nat. Biotechnol. 2010, 28 (5) 486-94
7. Dieterle, F.; Perentes, E.; Cordier, A.; Roth, D. R.; Verdes, P.; Grenet, O.; Pantano, S.; Moulin, P.; Wahl, D.; Mahl, A.; End, P.; Staedtler, F.; Legay, F.; Carl, K.; Laurie, D.; Chibout, S.-D.; Vonderscher, J.; Maurer, G. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury Nat. Biotechnol. 2010, 28 (5) 463-9
8. Dieterle, F.; Sistare, F.; Goodsaid, F.; Papaluca, M.; Ozer, J. S.; Webb, C. P.; Baer, W.; Senagore, A.; Schipper, M. J.; Vonderscher, J.; Sultana, S.; Gerhold, D. L.; Phillips, J. A.; Maurer, G.; Carl, K.; Laurie, D.; Harpur, E.; Sonee, M.; Ennulat, D.; Holder, D.; Andrews-Cleavenger, D.; Gu, Y.-Z.; Thompson, K. L.; Goering, P. L.; Vidal, J.-M.; Abadie, E.; Maciulaitis, R.; Jacobson-Kram, D.; Defelice, A. F.; Hausner, E. A.; Blank, M.; Thompson, A.; Harlow, P.; Throckmorton, D.; Xiao, S.; Xu, N.; Taylor, W.; Vamvakas, S.; Flamion, B.; Lima, B. S.; Kasper, P.; Pasanen, M.; Prasad, K.; Troth, S.; Bounous, D.; Robinson-Gravatt, D.; Betton, G.; Davis, M. A.; Akunda, J.; McDuffie, J. E.; Suter, L.; Obert, L.; Guffroy, M.; Pinches, M.; Jayadev, S.; Blomme, E. A.; Beushausen, S. A.; Barlow, V. G.; Collins, N.; Waring, J. Honor, D.; Snook, S.; Lee, J.; Rossi, P.; Walker, E.; Mattes, W., Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium Nat. Biotechnol. 2010, 28 (5) 455-62
9. Thongboonkerd, V. Current status of renal and urinary proteomics: ready for routine clinical application? Nephrol. Dial. Transplant 2010, 25 (1) 11-6
10. Cho, E.-H.; Kim, M.-R.; Kim, H.-J.; Lee, D.-Y.; Kim, P.-K.; Choi, K. M.; Ryu, O.-H.; Kim, C.-W. The discovery of biomarkers for type 2 diabetic nephropathy by serum proteome analysis Proteomics Clin. Appl. 2007, 1, 352-361
11. Yang, Y.-H.; Zhang, S.; Cui, J.-F.; Lu, B.; Dong, X.-H.; Song, X.-Y.; Liu, Y.-K.; Zhu, X.-X.; Hu, R.-M. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy Diabet. Med. 2007, 24 (12) 1386-92 (Pubitemid 350179452)
12. Higgins, J. P. T.; Wang, L.; Kambham, N.; Montgomery, K.; Mason, V.; Vogelmann, S. U.; Lemley, K. V.; Brown, P. O.; Brooks, J. D.; van de Rijn, M. Gene expression in the normal adult human kidney assessed by complementary DNA microarray Mol. Biol. Cell 2004, 15 (2) 649-56 (Pubitemid 38146481)
13. Park, M.-R.; Wang, E.-H.; Jin, D.-C.; Cha, J.-H.; Lee, K.-H.; Yang, C.-W.; Kang, C.-S.; Choi, Y.-J. Establishment of a 2-D human urinary proteomic map in IgA nephropathy Proteomics 2006, 6 (3) 1066-76 (Pubitemid 43260231)
14. Uhlen, M.; Oksvold, P.; Fagerberg, L.; Lundberg, E.; Jonasson, K.; Forsberg, M.; Zwahlen, M.; Kampf, C.; Wester, K.; Hober, S.; Wernerus, H.; Bjorling, L.; Ponten, F. Towards a knowledge-based Human Protein Atlas Nat. Biotechnol. 2010, 28 (12) 1248-50
15. Schwenk, J. M.; Igel, U.; Neiman, M.; Langen, H.; Becker, C.; Bjartell, A.; Ponten, F.; Wiklund, F.; Gronberg, H.; Nilsson, P.; Uhlen, M. Towards next generation plasma profiling via heat-induced epitope retrieval and array-based assays Mol. Cell. Proteomics 2010, 9 (11) 2497-507
16. Schwenk, J. M.; Gry, M.; Rimini, R.; Uhlen, M.; Nilsson, P. Antibody suspension bead arrays within serum proteomics J. Proteome Res. 2008, 7 (8) 3168-79
17. Schwenk, J. M.; Lindberg, J.; Sundberg, M.; Uhlen, M.; Nilsson, P. Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics Mol. Cell. Proteomics 2007, 6 (1) 125-32 (Pubitemid 46152697)
18. Nygren, P. A.; Eliasson, M.; Abrahmsen, L.; Uhlen, M.; Palmcrantz, E. Analysis and use of the serum albumin binding domains of streptococcal protein G J. Mol. Recognit. 1988, 1 (2) 69-74
19. Hamsten, C.; Neiman, M.; Schwenk, J. M.; Hamsten, M.; March, J. B.; Persson, A. Recombinant surface proteomics as a tool to analyze humoral immune responses in bovines infected by Mycoplasma mycoides subsp. mycoides small colony type Mol Cell Proteomics 2009, 8 (11) 2544-54
20. Ihaka, R.; Gentleman, R. R: a language for data analysis and graphics J. Comput. Graphical Stat. 1996, 5, 299-314
21. Dieterle, F.; Ross, A.; Schlotterbeck, G.; Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics Anal. Chem. 2006, 78 (13) 4281-90
22. Schwenk, J. M.; Igel, U.; Kato, B. S.; Nicholson, G.; Karpe, F.; Uhlen, M.; Nilsson, P. Comparative protein profiling of serum and plasma using an antibody suspension bead array approach Proteomics 2010, 10 (3) 532-540
23. Ayoglu, B.; Haggmark, A.; Neiman, M.; Igel, U.; Uhlen, M.; Schwenk, J. M.; Nilsson, P. Systematic antibody and antigen-based proteomic profiling with microarrays Expert Rev. Mol. Diagn. 2011, 11 (2) 219-34
24. Roark, E. E.; Keene, D. R.; Haudenschild, C. C.; Godyna, S.; Little, C. D.; Argraves, W. S. The Association of Human Fibulin-1 with Elastic Fibers: an Immunohistological, Ultrastructural, and RNA Study J. Histochem. Cytochem. 1995, 43 (4) 401-11
25. Argraves, W. S.; Tran, H.; Burgess, W. H.; Dickerson, K. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure J. Cell Biol. 1990, 111 (6 Pt 2) 3155-64 (Pubitemid 120034050)
26. Argraves, W. S.; Dickerson, K.; Burgess, W. H.; Ruoslahti, E. Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain Cell 1989, 58 (4) 623-9 (Pubitemid 19210956)
27. Singh, U.; Sun, T.; Larsson, T.; Elliott, R. W.; Kostka, G.; Fundele, R. H. Expression and functional analysis of fibulin-1 (Fbln1) during normal and abnormal placental development of the mouse Placenta 2006, 27 (9-10) 1014-21 (Pubitemid 44204027)
28. Kostka, G.; Giltay, R.; Bloch, W.; Addicks, K.; Timpl, R.; Fassler, R.; Chu, M. L. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice Mol. Cell. Biol. 2001, 21 (20) 7025-34 (Pubitemid 32911262)
29. Ottervald, J.; Franzen, B.; Nilsson, K.; Andersson, L. I.; Khademi, M.; Eriksson, B.; Kjellstrom, S.; Marko-Varga, G.; Vegvari, A.; Harris, R. A.; Laurell, T.; Miliotis, T.; Matusevicius, D.; Salter, H.; Ferm, M.; Olsson, T. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers J. Proteomics 2010, 73 (6) 1117-32
30. Kubista, B.; Klinglmueller, F.; Bilban, M.; Pfeiffer, M.; Lass, R.; Giurea, A.; Funovics, P. T.; Toma, C.; Dominkus, M.; Kotz, R.; Thalhammer, T.; Trieb, K.; Zettl, T.; Singer, C. F. Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma Int. Orthop. 2010, 1, 11
31. Greene, L. M.; Twal, W. O.; Duffy, M. J.; McDermott, E. W.; Hill, A. D.; O'Higgins, N. J.; McCann, A. H.; Dervan, P. A.; Argraves, W. S.; Gallagher, W. M. Elevated expression and altered processing of fibulin-1 protein in human breast cancer Br. J. Cancer 2003, 88 (6) 871-8 (Pubitemid 36520874)
32. Garcia, A.; Eiras, S.; Parguina, A. F.; Alonso, J.; Rosa, I.; Salgado-Somoza, A.; Rico, T. Y.; Teijeira-Fernandez, E.; Gonzalez-Juanatey, J. R. High-resolution two-dimensional gel electrophoresis analysis of atrial tissue proteome reveals down-regulation of fibulin-1 in atrial fibrillation Int. J. Cardiol. 2010, 150 (3) 283-90
33. Argraves, W. S.; Greene, L. M.; Cooley, M. A.; Gallagher, W. M. Fibulins: physiological and disease perspectives EMBO Rep. 2003, 4 (12) 1127-31 (Pubitemid 38088406)
34. Thongboonkerd, V.; Barati, M. T.; McLeish, K. R.; Benarafa, C.; Remold-O'Donnell, E.; Zheng, S.; Rovin, B. H.; Pierce, W. M.; Epstein, P. N.; Klein, J. B. Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis J. Am. Soc. Nephrol. 2004, 15 (3) 650-62 (Pubitemid 38294795)
35. Rossing, K.; Mischak, H.; Dakna, M.; Zurbig, P.; Novak, J.; Julian, B. A.; Good, D. M.; Coon, J. J.; Tarnow, L.; Rossing, P. Network, P., Urinary proteomics in diabetes and CKD J. Am. Soc. Nephrol. 2008, 19 (7) 1283-90
36. Poetz, O.; Henzler, T.; Hartmann, M.; Kazmaier, C.; Templin, M. F.; Herget, T.; Joos, T. O. Sequential multiplex analyte capturing for phosphoprotein profiling Mol. Cell. Proteomics 2010, 9 (11) 2474-81